VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.
Show more...
FAQ
VivoSim Labs 今天的股價是多少?▼
VIVS 目前價格為 $0.28 USD,過去 24 小時下跌了 -4.36%。在圖表上更密切關注 VivoSim Labs 股票的表現。
VivoSim Labs 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 XNAS 交易所,VivoSim Labs 的股票以代號 VIVS 進行交易。
VivoSim Labs 的股價在上漲嗎?▼
VIVS 股票較上週下跌 -4.42%,本月下跌 -19.12%,過去一年 VivoSim Labs 下跌 -88.58%。
VivoSim Labs 的市值是多少?▼
今天 VivoSim Labs 的市值為 3.73M
VivoSim Labs 下一次財報日期是什麼時候?▼
VivoSim Labs 將於 November 05, 2026 公布下一次財報。
VivoSim Labs 去年的營收是多少?▼
VivoSim Labs 去年的營收為 131,000USD。
VivoSim Labs 去年的淨利是多少?▼
VIVS 去年的淨收益為 -13.84MUSD。
VivoSim Labs 有多少名員工?▼
截至 September 01, 2026,公司共有 11 名員工。
VivoSim Labs 位於哪個產業?▼
VivoSim Labs從事於Health & Wellness產業。
VivoSim Labs 何時完成拆股?▼
VivoSim Labs 上次拆股發生於 March 21, 2025,比例為 1:12。
VivoSim Labs 的總部在哪裡?▼
VivoSim Labs 的總部位於 美國 的 SAN DIEGO。